Steven Cohen’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-175,000
| Closed | -$20.2M | – | 3025 |
|
|
2023
Q3 | $20.2M | Buy |
+175,000
| New | +$18.8M | 0.06% | 401 |
|
|
2022
Q4 | – | Sell |
-2,094,400
| Closed | -$130M | – | 1915 |
|
|
2022
Q3 | $130M | Buy |
+2,094,400
| New | +$146M | 0.52% | 32 |
|
|
2021
Q4 | – | Sell |
-203,378
| Closed | -$22.3M | – | 1421 |
|
|
2021
Q3 | $22.3M | Sell |
203,378
-852,493
| -81% | -$88.5M | 0.1% | 276 |
|
|
2021
Q2 | $98.9M | Buy |
+1,055,871
| New | +$97.2M | 0.44% | 42 |
|
|
2020
Q4 | – | Sell |
-443,270
| Closed | -$34.4M | – | 1241 |
|
|
2020
Q3 | $34.4M | Buy |
+443,270
| New | +$30.5M | 0.18% | 155 |
|
|
2019
Q3 | – | Sell |
-5,200
| Closed | -$125K | – | 1628 |
|
|
2019
Q2 | $125K | Buy |
+5,200
| New | +$132K | ﹤0.01% | 1018 |
|
|
2019
Q1 | – | Sell |
-312,800
| Closed | -$6.11M | – | 1340 |
|
|
2018
Q4 | $6.11M | Buy |
+312,800
| New | +$6.13M | 0.03% | 513 |
|
|
2018
Q2 | – | Sell |
-1,312,900
| Closed | -$18.6M | – | 1282 |
|
|
2018
Q1 | $18.6M | Buy |
1,312,900
+940,100
| +252% | +$13.9M | 0.08% | 305 |
|
|
2017
Q4 | $5.44M | Sell |
372,800
-2,436,700
| -87% | -$34.2M | 0.02% | 575 |
|
|
2017
Q3 | $35.6M | Sell |
2,809,500
-844,000
| -23% | -$10.7M | 0.16% | 165 |
|
|
2017
Q2 | $43.4M | Buy |
3,653,500
+3,226,300
| +755% | +$40.1M | 0.24% | 112 |
|
|
2017
Q1 | $6.31M | Sell |
427,200
-145,700
| -25% | -$2.36M | 0.04% | 486 |
|
|
2016
Q4 | $9.27M | Buy |
572,900
+63,500
| +12% | +$1.15M | 0.06% | 332 |
|
|
2016
Q3 | $9.23M | Buy |
509,400
+149,600
| +42% | +$2.92M | 0.06% | 292 |
|
|
2016
Q2 | $5.93M | Sell |
359,800
-659,600
| -65% | -$10.7M | 0.04% | 391 |
|
|
2016
Q1 | $16.9M | Buy |
+1,019,400
| New | +$17.8M | 0.13% | 193 |
|
|
2015
Q4 | – | Sell |
-900
| Closed | -$18K | – | 916 |
|
|
2015
Q3 | $18K | Sell |
900
-324,100
| -100% | -$10.2M | ﹤0.01% | 731 |
|
|
2015
Q2 | $11.3M | Buy |
325,000
+91,100
| +39% | +$2.78M | 0.08% | 300 |
|
|
2015
Q1 | $6.07M | Sell |
233,900
-2,380,800
| -91% | -$43.6M | 0.04% | 407 |
|
|
2014
Q4 | $33.7M | Buy |
2,614,700
+1,680,304
| +180% | +$21M | 0.24% | 145 |
|
|
2014
Q3 | $11.5M | Buy |
+934,396
| New | +$10.9M | 0.09% | 266 |
|
Other funds holding HZNP
IA
BTI
VWA
FSWA
BCMLT
HNB
Steven Cohen's HZNP Position: Q4 2023 in Review
Steven Cohen sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 175,000 shares — an estimated $20.2M sold.
Steven Cohen first reported a position in HZNP in Q3 2014 and held it in 21 quarters. The position peaked at $130M in Q3 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.
- Steven Cohen reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
- Steven Cohen sold 175,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $20.2M.
- Steven Cohen first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 21 quarters.
- Steven Cohen's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $130M in Q3 2022.
- 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.
Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.